Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.
Ther Adv Med Oncol
; 13: 17588359211019675, 2021.
Article
in En
| MEDLINE
| ID: mdl-34178121
Full text:
1
Database:
MEDLINE
Type of study:
Guideline
Language:
En
Journal:
Ther Adv Med Oncol
Year:
2021
Type:
Article
Affiliation country:
Austria